Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses (Q83305660)
Jump to navigation
Jump to search
scientific article published on 23 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses |
scientific article published on 23 January 2012 |
Statements
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses (English)
W E Pierceall
K A Olaussen
V Rousseau
E Brambilla
K M Sprott
T Le Chevalier
R Pirker
C Jiang
M Filipits
Y Chen
J L Kutok
D T Weaver
B E Ward
23 January 2012